featured
Nivolumab in Children and Young Adults With Relapsed or Refractory Solid Tumors or Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab in Children and Young Adults With Relapsed or Refractory Solid Tumours or Lymphoma (ADVL1412): A Multicentre, Open-Label, Single-Arm, Phase 1-2 Trial
Lancet Oncol 2020 Mar 16;[EPub Ahead of Print], KL Davis, E Fox, MS Merchant, JM Reid, RA Kudgus, X Liu, CG Minard, S Voss, SL Berg, BJ Weigel, CL MackallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.